Pan Canadian Pharmaceutical Alliance

pan-Canadian Pharmaceutical Alliance (pCPA): March 2019 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance (pCPA) has issued the status of brand negotiations as of March 31, 2019. Highlights since the last update include: 5 negotiations completed for a total of 247 completed negotiations 2 negotiations closed, for a total of 35 closed negotiations No new files closed without negotiations, for a total of 63 declined negotiations 8 products completed CADTH…

pan-Canadian Pharmaceutical Alliance (pCPA): February 2019 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of February 28, 2019. The key highlights since the last update are: 8 negotiations were completed for a total of 242 completed negotiations No negotiations were closed, for a total of 33 closed negotiations The pCPA decided to decline negotiations on 1 file, for a total…

pan-Canadian Pharmaceutical Alliance (pCPA): January 2019 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of January 31, 2019. The key highlights since the last update are: 3 negotiations were completed for a total of 234 completed negotiations 3 negotiations were closed, for a total of 33 closed negotiations The pCPA decided to decline negotiations on 2 files, for a total…

pan-Canadian Pharmaceutical Alliance (pCPA): December 2018 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) issued the status of brand negotiations as of December 31, 2018. The key highlights since the November update are: 5 products received a final HTA recommendation, for a total of 13 files under consideration 2 products initiated pCPA negotiations, for a total of 46 active negotiations 7 negotiations were completed for a total of…

pan-Canadian Pharmaceutical Alliance (pCPA): November 2018 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of November 30, 2018. The key highlights since the October update are: 7 new drug products have initiated pCPA negotiations, for a total of 51 active negotiations; 9 negotiations were completed for a total of 225 completed negotiations; and 2 negotiations were closed since the last…

pan-Canadian Pharmaceutical Alliance (pCPA): October 2018 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of October 31, 2018. The key highlights since the September update are: 6 new drug products have initiated pCPA negotiations, for a total of 57 active negotiations; 2 negotiations were completed for a total of 216 completed negotiations; and 1 negotiation was closed since the last…

Panel 4: Pan-Canadian Pharmaceutical Alliance   Panel Description: This panel will focus on recent events surrounding the pCPA and how public payers believe that PMPRB reform may impact upcoming pCPA negotiations. Moderator: Sherry O’Quinn Panelists: Imran Ali, Jessica Arias and Heather McDonald Sherry O’Quinn: Our focus is on recent events around the pCPA and the pharmaceutical landscape. A lot of this discussion is framed around healthcare sustainability. Here to take…

pan-Canadian Pharmaceutical Alliance (pCPA): September 2018 Negotiation Status Update   The pan-Canadian Pharmaceutical Alliance Office (pCPAO) has issued the status of brand negotiations as of September 30, 2018. This month, MORSE Consulting Inc. provides our standard update along with two charts demonstrating the trends for the average time under consideration and average duration of negotiation for completed and closed files from August 2017 to September 2018. Of note: Average Time…

pCPA Biosimilars/Biologics Policy Directions Webinar   On Tuesday September 25, 2018 the pan-Canadian Pharmaceutical Alliance Office (pCPAO) hosted a one-hour webinar for industry to introduce the Biologics Policy Directions and pCPA Negotiations document. The objectives of the webinar were to: Present the pCPA Biologics Policy Directions & pCPA Negotiations document; and Invite and address industry feedback. This edition of MORSE Signals provides an overview of the webinar and provides key…

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The August 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The key highlights since the last update are: 7 negotiations were completed, while none were closed for a total of 235 completed/closed negotiations; 9 new drug products have initiated pCPA negotiations, for a total of 48 active negotiations; No new drug products were added to the “No pCPA Negotiations”…

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The July 31, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The key highlights since the last update are: 9 negotiations were completed, while none were closed for a total of 228 completed/closed negotiations; 8 new drug products have initiated pCPA negotiations, for a total of 46 active negotiations; No new drug products were added to the “No pCPA Negotiations”…

pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update   The June 30, 2018 update has been issued by the pan-Canadian Pharmaceutical Alliance. The key highlights since the last update are: Three negotiations were completed, while one negotiation was closed for a total of 193 completed negotiations and 26 closed negotiations; Eight new drug products have initiated pCPA negotiations, for a total of 47 active negotiations; No new drug products were added…

pCPA Brand Process Guidelines Webinar   On Friday, June 22nd, 2018 the pan-Canadian Pharmaceutical Alliance Office (pCPAO) hosted an industry consultation session via webinar, on the newly completed pCPA Brand Process Guidelines (“the Guidelines”). The objective of this webinar was to: introduce the Guidelines and supportive documents developed by the pCPA; and invite industry’s initial feedback. This edition of MORSE Signals provides an overview of the webinar and outlines key…